145 related articles for article (PubMed ID: 37851320)
1. Compromised diabetic heart function is not affected by miR-378a upregulation upon hyperglycemia.
Florczyk-Soluch U; Polak K; Sabo R; Martyniak A; Stępniewski J; Dulak J
Pharmacol Rep; 2023 Dec; 75(6):1556-1570. PubMed ID: 37851320
[TBL] [Abstract][Full Text] [Related]
2. Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes.
Martyniak A; Andrysiak K; Motais B; Coste S; Podkalicka P; Ferdek P; Stępniewski J; Dulak J
J Mol Cell Cardiol; 2021 Nov; 160():128-141. PubMed ID: 34329686
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
4. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
[TBL] [Abstract][Full Text] [Related]
6. miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy.
Raut SK; Kumar A; Singh GB; Nahar U; Sharma V; Mittal A; Sharma R; Khullar M
Cardiovasc Ther; 2015 Jun; 33(3):89-97. PubMed ID: 25781190
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy.
Singh GB; Raut SK; Khanna S; Kumar A; Sharma S; Prasad R; Khullar M
Mol Cell Biochem; 2017 Jan; 424(1-2):1-11. PubMed ID: 27696308
[TBL] [Abstract][Full Text] [Related]
8. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
9. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
[TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
Tang Q; Len Q; Liu Z; Wang W
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
14. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity.
Jin L; Geng L; Ying L; Shu L; Ye K; Yang R; Liu Y; Wang Y; Cai Y; Jiang X; Wang Q; Yan X; Liao B; Liu J; Duan F; Sweeney G; Woo CWH; Wang Y; Xia Z; Lian Q; Xu A
Circulation; 2022 Nov; 146(20):1537-1557. PubMed ID: 36134579
[TBL] [Abstract][Full Text] [Related]
15. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
[TBL] [Abstract][Full Text] [Related]
16. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
[TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy.
Jin B; Wang J; Chen Y; Zuo W; Hong B; Li J; Huang F; Zhang M; Wang Y
Int Immunopharmacol; 2023 Jul; 120():110280. PubMed ID: 37216798
[TBL] [Abstract][Full Text] [Related]
19. miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.
Raut SK; Singh GB; Rastogi B; Saikia UN; Mittal A; Dogra N; Singh S; Prasad R; Khullar M
Mol Cell Biochem; 2016 Jun; 417(1-2):191-203. PubMed ID: 27221738
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
